東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Linked to FindBook

Google Book

Amazon

博客來

Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes.

Record Type:	Electronic resources : Monograph/item
Title/Author:	Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes./
Author:	Yu, Gary Z.
Published:	Ann Arbor : ProQuest Dissertations & Theses, : 2020,
Description:	231 p.
Notes:	Source: Dissertations Abstracts International, Volume: 83-05, Section: B.
Contained By:	Dissertations Abstracts International83-05B.
Subject:	Physiology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28808960
ISBN:	9798494446084

Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes.
Yu, Gary Z.

Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes. - Ann Arbor : ProQuest Dissertations & Theses, 2020 - 231 p.

Source: Dissertations Abstracts International, Volume: 83-05, Section: B.

Thesis (Ph.D.)--University of Pittsburgh, 2020.

This item must not be sold to any third party vendors.

Microvascular obstruction is a common repercussion of percutaneous coronary intervention in treating acute myocardial infarction, and results from a combination of downstream microembolization, ischemia-reperfusion injury, and inflammation. Ultrasound-targeted microbubble cavitation (UTMC) uses external therapeutic ultrasound pulsation to target intravascularly infused microbubble contrast agents to produce shear stresses which mechanically disrupt obstructing microemboli. This work aims to enhance the therapeutic effects of UTMC through synergistic co-administration of nitrite for enhancement of perfusion and nitric oxide bioavailability (Aim 1) and development of a novel microbubble agent using nitro-alkenes for therapeutic reduction of inflammation after ischemia-reperfusion injury (Aim 2).For characterization and optimization of nitrite co-therapy with UTMC, a rat gastrocnemius model was used with contrast-enhanced ultrasound imaging. A nitric oxide porphyrinic membrane catheter probe was inserted into the treatment site for real-time measurement of nitric oxide concentration changes. In addition to nitrite co-therapy, effects of administering an endothelial nitric oxide synthase inhibitor as well as varying microbubble concentration and therapeutic ultrasound pressure were studied. Results showed that UTMC and nitrite demonstrated positive synergy for enhancing nitric oxide concentration and perfusion which depended on functional endothelial nitric oxide synthase.After a novel nitro-alkene microbubble agent was synthesized and characterized, it was applied in both healthy and ischemia-reperfusion injury rat gastrocnemius models. Tissue samples were collected after treatment for quantification of nitro-alkene delivery, changes in inflammatory gene expression, and contrast-enhanced ultrasound imaging was used to quantify changes in hindlimb perfusion after treatment. Results showed that incorporation of the nitro-alkene into a microbubble formulation with UTMC greatly enhanced targeted tissue delivery of the nitro-alkene compared to co-infusion with standard microbubbles and systemic infusion alone. In addition, nitro-alkene microbubble UTMC resulted in greatly enhanced perfusion as well as decreases in inflammatory gene expression.In all, both of these applications of enhancing UTMC therapy demonstrate significant mechanistic interactions with endogenous nitric oxide metabolism and may serve to enhance nitric oxide bioavailability through different pathways. They may also improve the relevance of UTMC in treating the biological sequelae of microvascular obstruction without compromising its mechanical function in disrupting microemboli.

ISBN: 9798494446084Subjects--Topical Terms:

518431
Physiology.

Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes.
LDR:04018nmm a2200445 4500 001 2347687
005 20220823142332.5
008 241004s2020 ||||||||||||||||| ||eng d
020 $a 9798494446084
035 $a (MiAaPQ)AAI28808960
035 $a (MiAaPQ)Pittsburgh38533
035 $a AAI28808960
040 $a MiAaPQ $c MiAaPQ
100 1 $a Yu, Gary Z. $3 3686969
245 1 0 $a Applications of Ultrasound-Targeted Microbubble Cavitation with Sodium Nitrite and Nitro-Alkenes.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2020
300 $a 231 p.
500 $a Source: Dissertations Abstracts International, Volume: 83-05, Section: B.
500 $a Advisor: Kim, Kang;Aizenstein, Howard;Borovetz, Harvey;Shroff, Sanjeev;Pacella, John.
502 $a Thesis (Ph.D.)--University of Pittsburgh, 2020.
506 $a This item must not be sold to any third party vendors.
520 $a Microvascular obstruction is a common repercussion of percutaneous coronary intervention in treating acute myocardial infarction, and results from a combination of downstream microembolization, ischemia-reperfusion injury, and inflammation. Ultrasound-targeted microbubble cavitation (UTMC) uses external therapeutic ultrasound pulsation to target intravascularly infused microbubble contrast agents to produce shear stresses which mechanically disrupt obstructing microemboli. This work aims to enhance the therapeutic effects of UTMC through synergistic co-administration of nitrite for enhancement of perfusion and nitric oxide bioavailability (Aim 1) and development of a novel microbubble agent using nitro-alkenes for therapeutic reduction of inflammation after ischemia-reperfusion injury (Aim 2).For characterization and optimization of nitrite co-therapy with UTMC, a rat gastrocnemius model was used with contrast-enhanced ultrasound imaging. A nitric oxide porphyrinic membrane catheter probe was inserted into the treatment site for real-time measurement of nitric oxide concentration changes. In addition to nitrite co-therapy, effects of administering an endothelial nitric oxide synthase inhibitor as well as varying microbubble concentration and therapeutic ultrasound pressure were studied. Results showed that UTMC and nitrite demonstrated positive synergy for enhancing nitric oxide concentration and perfusion which depended on functional endothelial nitric oxide synthase.After a novel nitro-alkene microbubble agent was synthesized and characterized, it was applied in both healthy and ischemia-reperfusion injury rat gastrocnemius models. Tissue samples were collected after treatment for quantification of nitro-alkene delivery, changes in inflammatory gene expression, and contrast-enhanced ultrasound imaging was used to quantify changes in hindlimb perfusion after treatment. Results showed that incorporation of the nitro-alkene into a microbubble formulation with UTMC greatly enhanced targeted tissue delivery of the nitro-alkene compared to co-infusion with standard microbubbles and systemic infusion alone. In addition, nitro-alkene microbubble UTMC resulted in greatly enhanced perfusion as well as decreases in inflammatory gene expression.In all, both of these applications of enhancing UTMC therapy demonstrate significant mechanistic interactions with endogenous nitric oxide metabolism and may serve to enhance nitric oxide bioavailability through different pathways. They may also improve the relevance of UTMC in treating the biological sequelae of microvascular obstruction without compromising its mechanical function in disrupting microemboli.
590 $a School code: 0178.
650 4 $a Physiology. $3 518431
650 4 $a Clinical medicine. $3 804916
650 4 $a Fatty acids. $3 897910
650 4 $a Skin. $3 843661
650 4 $a Energy. $3 876794
650 4 $a Blood. $3 641576
650 4 $a Visualization. $3 586179
650 4 $a Vibration. $3 544256
650 4 $a Drug dosages. $3 3557732
650 4 $a Composite materials. $3 654082
650 4 $a Oxidative stress. $3 899116
650 4 $a Propagation. $3 3680519
650 4 $a Cavitation. $3 838264
650 4 $a Gene expression. $3 643979
650 4 $a Lithotripsy. $3 3686970
650 4 $a Design. $3 518875
650 4 $a Travel. $3 585743
650 4 $a Arrays. $3 3681398
650 4 $a Contrast agents. $3 3681940
650 4 $a Acoustics. $3 879105
650 4 $a Ischemia. $3 867591
650 4 $a Ultrasonic imaging. $3 828386
650 4 $a Human body. $3 955010
650 4 $a Bioinformatics. $3 553671
650 4 $a Biology. $3 522710
650 4 $a Medical imaging. $3 3172799
650 4 $a Genetics. $3 530508
650 4 $a Materials science. $3 543314
650 4 $a Medicine. $3 641104
650 4 $a Morphology. $3 591167
650 4 $a Physics. $3 516296
650 4 $a Recreation. $3 535376
690 $a 0791
690 $a 0389
690 $a 0986
690 $a 0719
690 $a 0715
690 $a 0306
690 $a 0574
690 $a 0369
690 $a 0794
690 $a 0564
690 $a 0287
690 $a 0605
690 $a 0814
710 2 $a University of Pittsburgh. $3 958527
773 0 $t Dissertations Abstracts International $g 83-05B.
790 $a 0178
791 $a Ph.D.
792 $a 2020
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28808960